Bristol Myers Squibb (BMY) Q3 2023 Earnings Call Transcript

BMY earnings call for the period ending September 30, 2023.

Related Keywords

Sweden ,United States ,France ,Norway ,Canada ,Robyn Karnauskas Truist ,Chris Shibutani ,Terence Flynn Morgan Stanley ,Seamus Fernandez Guggenheim ,Bristol Myers Squibb ,Evan Seigerman ,David Elkins ,Adam Lenkowsky ,Carter Gould Barclays ,Raymond James ,Samit Hirawat ,Olivia Brayer ,Chris Schott Jpmorgan ,Giovanni Caforio ,David Risinger ,Tim Anderson ,Luisa Hector ,Andrew Baum Citi ,Dane Leone ,Chris Schott ,Robyn Karnauskas ,Luisa Hector Berenberg ,Carter Gould ,Andrew Baum ,Seamus Fernandez ,Terence Flynn ,Mohit Bansal ,Chris Boerner ,Steven Scala ,David Risinger Leerink ,Chris Shibutani Goldman Sachs ,America Merrill Lynch ,Olivia Brayer Cantor Fitzgerald ,Geoff Meacham ,Cantor Fitzgerald ,Company Analyst ,Wolfe Research ,Geoff Meacham Bank ,Tim Anderson Wolfe Research Analyst ,Morgan Stanley ,Wells Fargo ,Head Of Global Drug Development ,Barclays ,Goldman Sachs ,Stim Power ,Bristol Myers ,Motley Fool Stock Advisor ,Stock Advisor ,Chief Executive ,Operating Officer ,Fast Track Designation ,Chief Operating Officer ,Capital Markets ,Medical Officer ,Global Drug ,Fargo Securities ,Chief Commercialization ,Berenberg Capital Markets ,Guggenheim Partners ,Chief Medical Officer ,Leerink Partners ,